Skip to main navigation Skip to search Skip to main content

A Phase 2/3, Randomized, Observer-Blind, Placebo Controlled, Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 SARS CoV 2 Vaccine in Healthy Adolescents 12 to <18 years of age

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date01/22/21 → 01/21/26

Funding

  • ModernaTX: $575,956.40